Phase I Trial of Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Ribociclib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 17 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Jun 2017 Status changed from not yet recruiting to recruiting.
- 24 May 2017 Planned initiation date changed from 1 May 2017 to 1 Jun 2017.